Industry5 min read
EASO Now Ranks Tirzepatide Above Semaglutide
Europe's top obesity body updated its algorithm May 12 — tirzepatide leads for weight loss, semaglutide for liver fibrosis. What it means for buyers.
Peptide News & Analysis
FDA actions, trial readouts, vendor coverage and pricing reports — curated for peptide buyers and clinicians.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
Latest News
Industry7 min read
MariTide Switch Trial: From Weekly GLP-1 to Monthly
Amgen's 300-patient MARITIME-Switch trial tests transitioning from weekly semaglutide or tirzepatide to MariTide every 8 weeks or quarterly.
Industry4 min read
What Are Peptides? How They Work in 2026
Peptides are amino acid chains that signal specific receptors. Key categories: growth hormone, metabolic, healing, and cognitive.
Industry14 min read
Peptide Stacking: 13 Best Combos & Doses
Not all stacks are equal — 3 combos stand out for synergy. 13 stacks with exact doses, timing, and which combos to avoid.
Industry12 min read
How Peptides Work: 4 Key Mechanisms
GH release, mitochondrial repair, metabolic signaling, and immune modulation — four pathways that explain every peptide.
Industry8 min read
FDA Fast-Tracks Liraglutide Knee Injection for OA
FDA gave 4P004 — intra-articular liraglutide for knee osteoarthritis — Fast Track in April. What it means for GLP-1 buyers and OA patients.
Industry9 min read
Tirzepatide Loses More Muscle Than Semaglutide: 670k Data
New nference preprint of 670,422 GLP-1 users shows tirzepatide patients lose 2% more lean mass at 12 months. Depletive metabotype hits 10.3%.
Industry6 min read
Semaglutide 7.2 mg: Early Responders Hit 27.7%
Novo's ECO 2026 sub-analysis shows early-responder patients lost nearly 28% on 7.2 mg. What it means for research-peptide dosing and vendor sourcing.
Industry5 min read
Orforglipron Pill Holds 79% of Weight Loss After Stopping Shots
New ATTAIN-MAINTAIN trial: switching from injectable semaglutide or tirzepatide to daily orforglipron held 75-79% of weight loss over 52 weeks.
Industry7 min read
How Much Bac Water Per Peptide Vial: Chart + Math
One reconstitution ratio gets the math right every time. Full chart for BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, and retatrutide.
Industry7 min read
GLP-1s Cause Sarcopenia in Seniors: 2026 Trial Data
A 24-month semaglutide cohort in adults 65+ shows accelerated muscle loss + falling gait speed. What it means for older GLP-1 buyers.
Industry8 min read
Cloudy Peptide After Reconstitution: Safe to Inject?
Cloudy after mixing? Almost always the bac water — not the peptide. Whether it's safe to inject, the 7 causes ranked, and how to prevent it.
Industry8 min read
Where to Buy Bacteriostatic Water for Peptides
Three ways to buy bac water for peptides — vendor-sourced, pharmacy, or marketplace. Typical 30 mL runs $20-35. Which path gives you COA-verified quality without ruining a $300 vial.
Trials9 min read
MBX 4291: Monthly GLP-1 Hits 7% Weight Loss in Phase 1
MBX Biosciences' monthly GLP-1/GIP injection lost 7% at 8 weeks Phase 1 with no nausea. PK supports true monthly dosing. What buyers should know.
Industry5 min read
GLP-1s for the Brain: 53% Lower Dementia + Addiction Use
UCSF May 5 synthesis pulls dementia and addiction data into one frame. What semaglutide, tirzepatide, and brenipatide buyers should track.
Industry9 min read
Bac Water for GLP-1 Reconstitution: Sema, Tirz, Reta
Three GLP-1 compounds, three vial sizes, one bac water ratio that works. Why multi-month protocols make bac water non-negotiable.
Industry7 min read
Sports Medicine Names BPC-157, TB-500 Risks: What's Real
Peer-reviewed Sports Medicine paper flags BPC-157, TB-500, GHK-Cu — 40-75% of gray-market peptides fail purity. Where to source verified.
Industry6 min read
GLP-1 Pills Hit Brain Reward Circuit: New Mechanism
May 6 Nature study: oral GLP-1 pills reach the central amygdala and shut down hedonic eating — a circuit injectable peptides may not touch. What it means for buyers.